NeuroBo Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Strategic UpdatePRNewsWire • 04/15/21
NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for GemcabenePRNewsWire • 03/24/21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development ProgramPRNewsWire • 01/06/21